Nippon India Pharma Fund has announced change in investment factsheets and fund flash for the month ended May 31, 2026.

As on May 31, 2026, the total size of the Fund was Rs 8,635.75 crores, compared with Rs 8,365.40 crores in the last month. The Fund's NAV per unit was Rs 536.48 for Growth, while 52-Week High and Low ranges were Rs 549.25 and Rs 481.82 respectively.

The Equity - Sector Fund fund with Growth plan was launched on Jun 05, 2004 and managed by Fund Managers Sailesh Raj Bhan, Kinjal Desai.

The top five companies based on a percentage of total holdings were Sun Pharmaceutical Industries Limited (1152.63 Cr.), Lupin Limited (631.33 Cr.), Dr. Reddy's Laboratories Limited (580.02 Cr.), Cipla Limited (531.69 Cr.) and Divi's Laboratories Limited (500.53 Cr.).

Nippon India Pharma Fund is promoted by Nippon India Mutual Fund and managed by Nippon Life India Asset Management Ltd..